88 related articles for article (PubMed ID: 24567264)
21. Hyaluronic acid targets CD44 and inhibits FcepsilonRI signaling involving PKCdelta, Rac1, ROS, and MAPK to exert anti-allergic effect.
Kim Y; Lee YS; Hahn JH; Choe J; Kwon HJ; Ro JY; Jeoung D
Mol Immunol; 2008 May; 45(9):2537-47. PubMed ID: 18289679
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor-2 stimulates directed migration of periodontal ligament cells via PI3K/AKT signaling and CD44/hyaluronan interaction.
Shimabukuro Y; Terashima H; Takedachi M; Maeda K; Nakamura T; Sawada K; Kobashi M; Awata T; Oohara H; Kawahara T; Iwayama T; Hashikawa T; Yanagita M; Yamada S; Murakami S
J Cell Physiol; 2011 Mar; 226(3):809-21. PubMed ID: 20857427
[TBL] [Abstract][Full Text] [Related]
23. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression.
Levesque MC; Haynes BF
J Immunol; 1996 Feb; 156(4):1557-65. PubMed ID: 8568260
[TBL] [Abstract][Full Text] [Related]
24. N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model.
Baker DP; Lin EY; Lin K; Pellegrini M; Petter RC; Chen LL; Arduini RM; Brickelmaier M; Wen D; Hess DM; Chen L; Grant D; Whitty A; Gill A; Lindner DJ; Pepinsky RB
Bioconjug Chem; 2006; 17(1):179-88. PubMed ID: 16417267
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of binding site conformational switching in the CD44-hyaluronan protein-carbohydrate binding interaction.
Jamison FW; Foster TJ; Barker JA; Hills RD; Guvench O
J Mol Biol; 2011 Mar; 406(4):631-47. PubMed ID: 21216252
[TBL] [Abstract][Full Text] [Related]
26. Regulation of hyaluronan binding by F-actin and colocalization of CD44 and phosphorylated ezrin/radixin/moesin (ERM) proteins in myeloid cells.
Brown KL; Birkenhead D; Lai JC; Li L; Li R; Johnson P
Exp Cell Res; 2005 Feb; 303(2):400-14. PubMed ID: 15652352
[TBL] [Abstract][Full Text] [Related]
27. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
Afify A; Lynne LC; Howell L
Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
[TBL] [Abstract][Full Text] [Related]
28. Role of CD44 cytoplasmic domain in hyaluronan binding.
Perschl A; Lesley J; English N; Trowbridge I; Hyman R
Eur J Immunol; 1995 Feb; 25(2):495-501. PubMed ID: 7533087
[TBL] [Abstract][Full Text] [Related]
29. TNFalpha and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44.
Levesque MC; Haynes BF
Cell Immunol; 1999 May; 193(2):209-18. PubMed ID: 10222064
[TBL] [Abstract][Full Text] [Related]
30. von Willebrand factor contributes to longer half-life of PEGylated factor VIII in vivo.
Tang L; Leong L; Sim D; Ho E; Gu JM; Schneider D; Feldman RI; Monteclaro F; Jiang H; Murphy JE
Haemophilia; 2013 Jul; 19(4):539-45. PubMed ID: 23534820
[TBL] [Abstract][Full Text] [Related]
31. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg.
Annabi B; Bouzeghrane M; Moumdjian R; Moghrabi A; Béliveau R
J Neurochem; 2005 Aug; 94(4):906-16. PubMed ID: 15992376
[TBL] [Abstract][Full Text] [Related]
32. Polyethylene glycol conjugation of recombinant methioninase for cancer therapy.
Tan Y; Sun X; Xu M; An Z; Tan X; Han Q; Miljkovic DA; Yang M; Hoffman RM
Protein Expr Purif; 1998 Feb; 12(1):45-52. PubMed ID: 9473456
[TBL] [Abstract][Full Text] [Related]
33. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
Gross N; Balmas K; Brognara CB
Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
[TBL] [Abstract][Full Text] [Related]
34. Interactions between CD44 protein and hyaluronan: insights from the computational study.
Plazinski W; Knys-Dzieciuch A
Mol Biosyst; 2012 Feb; 8(2):543-7. PubMed ID: 22159602
[TBL] [Abstract][Full Text] [Related]
35. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
Bell SJ; Fam CM; Chlipala EA; Carlson SJ; Lee JI; Rosendahl MS; Doherty DH; Cox GN
Bioconjug Chem; 2008 Jan; 19(1):299-305. PubMed ID: 18020402
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes.
Bourguignon LY; Gilad E; Peyrollier K; Brightman A; Swanson RA
J Neurochem; 2007 May; 101(4):1002-17. PubMed ID: 17403031
[TBL] [Abstract][Full Text] [Related]
37. Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity.
Pepinsky RB; LePage DJ; Gill A; Chakraborty A; Vaidyanathan S; Green M; Baker DP; Whalley E; Hochman PS; Martin P
J Pharmacol Exp Ther; 2001 Jun; 297(3):1059-66. PubMed ID: 11356929
[TBL] [Abstract][Full Text] [Related]
38. Conjugation to 10 kDa Linear PEG Extends Serum Half-Life and Preserves the Receptor-Binding Ability of mmTRAIL with Minimal Stimulation of PEG-Specific Antibodies.
Nie Q; Jia D; Yang H; Feng Y; Fan Q; Shi Q; Wan L; Lu X
Mol Pharm; 2017 Feb; 14(2):502-512. PubMed ID: 28029256
[TBL] [Abstract][Full Text] [Related]
39. Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models.
Thompson CB; Shepard HM; O'Connor PM; Kadhim S; Jiang P; Osgood RJ; Bookbinder LH; Li X; Sugarman BJ; Connor RJ; Nadjsombati S; Frost GI
Mol Cancer Ther; 2010 Nov; 9(11):3052-64. PubMed ID: 20978165
[TBL] [Abstract][Full Text] [Related]
40. A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid.
Liu D; Sy MS
J Exp Med; 1996 May; 183(5):1987-94. PubMed ID: 8642309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
